Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pfizer Launches Embrex® Vaccine Manual Inovoject®

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
New, compact in ovo device for vaccine manufacturers.

Pfizer Animal Health Global Poultry has launched a new, compact in ovo device aimed at vaccine manufacturers and research institutes.

Embrex® Vaccine Manual Inovoject® (VMI) is the latest addition to the Embrex Vaccine Manufacturing Device (VMD) portfolio which already includes a range of in ovo devices used for the mass production of human influenza vaccines as well as other human and animal health egg-based vaccines.

This small, semi-automated device enables inoculation to be carried out in the laboratory setting, and so is aimed at vaccine manufacturers that require an alternative to high volume production. It could also be used for research and batch testing.

“The device is designed and produced specifically with the vaccine manufacturing environment in mind - for both human and animal health vaccines,” said Product Engineer, Joe Federowicz.

Federowicz continued, “It is only 30 inches wide, and thus can fit through ordinary laboratory doors. It is also fully enclosed so as to prevent dirt build up and other potential sources of contamination.”

According to Director, Gerardo Vera, Embrex VMI is likely to be of particular interest to vaccine manufacturers in Asia and Latin America markets.

“A typical animal health facility could probably install three to five of these machines, and each one would be used for a different vaccine,” Mr Vera said.

“The full-size Embrex Inovoject has been used by human vaccine manufacturers for many years for large scale flu vaccine production. The new Embrex VMI has the same industry-leading quality, features, functionality and reliability that customers have come to expect from the Embrex brand, which has been at the forefront of in ovo technology for 20 years,” said Mr Federowicz.

“We realized the need for an inoculation device which had the same engineering quality as other Embrex VMD products, but which could be installed in a much smaller area and was suited for smaller production runs.

“It took about a year to refine the design and bring it to market because the quality had to be superlative and up to industry standards. But I am really pleased with the result. The finish has to be seen to be believed: with no visible welds and mirror finish surfaces.”

Embrex VMI is available with the same world-class customer service and parts as offered with Pfizer Animal Health’s existing devices in the poultry business.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!